We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Ewa M. Davison Fenwick & West LLP

Results 1 to 5 of 5



Murky waters: post-approval regulatory activities and the § 271(e)(1) safe harbor *

USA - April 10 2013
On January 14, 2013, the U.S. Supreme Court refused to consider the U.S. Court of Appeals for the Federal Circuit's exclusion in Classen…

Co-authors: David Tellekson.


Final patent rules provide few surprises *

USA - August 27 2012
In mid-July, the United States Patent and Trademark Office began rolling out final versions of patent rules to implement the America Invents Act (AIA).

Co-authors: Melanie L. Mayer, Stuart P. Meyer.


PTO publishes final rules for contested patent cases *

USA - August 14 2012
Today, the U.S. Patent and Trademark Office ("PTO") published final rules for handling contested patent cases, such as those permitting third parties to initiate post-grant review of patents based on prior art.

Co-authors: Melanie L. Mayer, Stuart P. Meyer.


Supreme Court allows generic manufacturers to challenge overbroad use codes *

USA - June 5 2012
The United States Supreme Court ruled unanimously on April 17, 2012 that a generic drug manufacturer may file a counterclaim to force correction of an overbroad use code that encompasses unclaimed methods of using the drug at issue.

Co-authors: David Tellekson.


Supreme Court allows generic manufacturers to challenge overbroad use codes *

USA - April 18 2012
The United States Supreme Court has again reversed the Federal Circuit, ruling unanimously that a generic drug manufacturer may file a counterclaim to force correction of an overbroad use code that encompasses unclaimed methods of using the drug at issue. 

Co-authors: David Tellekson, Heather N. Mewes.